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Abstract
Background: Nanocrystalline silver dressings have anti-inflammatory activity, unlike solutions containing Ag
+ only,
which may be due to dissolution of multiple silver species. These dressings can only be used to treat surfaces.
Thus, silver-containing solutions with nanocrystalline silver properties could be valuable for treating hard-to-dress
surfaces and inflammatory conditions of the lungs and bowels. This study tested nanocrystalline silver-derived
solutions for anti-inflammatory activity.
Methods: Inflammation was induced on porcine backs using dinitrochlorobenzene. Negative and positive controls
were treated with distilled water. Experimental groups were treated with solutions generated by dissolving
nanocrystalline silver in distilled water adjusted to starting pHs of 4 (using CO2), 5.6 (as is), 7, and 9 (using Ca(OH)2).
Solution samples were analyzed for total silver. Daily imaging, biopsying, erythema and oedema scoring, and
treatments were performed for three days. Biopsies were processed for histology, immunohistochemistry (for IL-4,
IL-8, IL-10, TNF-a, EGF, KGF, KGF-2, and apoptotic cells), and zymography (MMP-2 and -9). One-way ANOVAs with
Tukey-Kramer post tests were used for statistical analyses.
Results: Animals treated with pH 7 and 9 solutions showed clear visual improvements. pH 9 solutions resulted in
the most significant reductions in erythema and oedema scores. pH 4 and 7 solutions also reduced oedema
scores. Histologically, all treatment groups demonstrated enhanced re-epithelialisation, with decreased
inflammation. At 24 h, pMMP-2 expression was significantly lowered with pH 5.6 and 9 treatments, as was aMMP-2
expression with pH 9 treatments. In general, treatment with silver-containing solutions resulted in decreased TNF-a
and IL-8 expression, with increased IL-4, EGF, KGF, and KGF-2 expression. At 24 h, apoptotic cells were detected
mostly in the dermis with pH 4 and 9 treatments, nowhere with pH 5.6, and in both the epidermis and dermis
with pH 7. Solution anti-inflammatory activity did not correlate with total silver content, as pH 4 solutions
contained significantly more silver than all others.
Conclusions: Nanocrystalline silver-derived solutions appear to have anti-inflammatory/pro-healing activity,
particularly with a starting pH of 9. Solutions generated differently may have varying concentrations of different
silver species, only some of which are anti-inflammatory. Nanocrystalline silver-derived solutions show promise for a
variety of anti-inflammatory treatment applications.
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Nanocrystalline silver dressings were originally intro-
duced as antimicrobial burn dressings about a decade
ago. Studies have since suggested that these dressings
have pro-healing and/or anti-inflammatory activity in
infected wounds, rashes, and meshed skin grafts[1-5].
Recently, studies have shown that, unlike solutions that
contain only Ag
+, nanocrystalline silver has anti-inflam-
matory activity independent of its antimicrobial activity
in a porcine model of contact dermatitis[6]. Visual and
histological signs of inflammation were reduced, apopto-
sis was induced in inflammatory cells of the dermis, and
expression of gelatinases and pro-inflammatory cyto-
kines transforming growth factor (TGF)-b, tumor necro-
sis factor (TNF)-a, and interleukin (IL)-8 were also
reduced[6]. A more recent study has suggested that this
effect may be translocatable or systemic, although the
effect was weaker with treatment away from the site of
injury relative to direct treatments[7]. Another study has
shown that, in a murine model of ulcerative colitis, pro-
prietary nanocrystalline silver nanodispersions in polyvi-
nyl alcohol/water delivered intracolonically or orally (at
10 times the dose) suppressed the expression of matrix
metalloproteinase (MMP)-9, TNF-a,I L - 1 b,a n dI L - 1 2
[8]. This suggests that nanocrystalline silver has anti-
inflammatory activity which could be used to treat inter-
nal epithelial tissues, as well as the skin.
The anti-inflammatory activity of nanocrystalline silver
may be due to its small grain size and polycrystallinity,
which together result in a high percentage of high
energy grain boundaries and defect structures from
which unique silver species can dissolve into aqueous
solution[9]. One of these unique species released into
solution is Ag
0, which is likely released in a cluster form
[9]. Ag
0 is the most likely species to have anti-inflamma-
tory activity, as other noble metals have demonstrated
similar activity[10-14].
While the anti-inflammatory activity of nanocrystalline
silver appears to be potent[6], in its current configura-
tion direct nanocrystalline silver dressing applications
are limited to treatment of surfaces, and even in surface
applications, tissue contact can be problematic. Since
nanocrystalline silver appears to be active via its dissolu-
tion products, it is possible that silver-containing solu-
tions could be generated which have some or all of the
properties of the nanocrystalline silver dressings. Solu-
tions with these properties would be valuable for anti-
inflammatory/pro-healing medical applications including
treatment of hard-to-dress surfaces, such as tunnelling
wounds, and inflammatory conditions of internal epithe-
lial tissues including the lungs (e.g. acute respiratory dis-
tress syndrome) and the gastrointestinal tract (e.g.
inflammatory bowel disease). The purpose of this study
was to test solutions, derived from nanocrystalline silver
under various conditions, for anti-inflammatory activity
in a known model of inflammation.
This study shows that nanocrystalline silver-derived
solutions have anti-inflammatory and pro-healing prop-
erties in the model chosen, as treatment with these solu-
tions resulted in visual and histological improvements.
These improvements corresponded to reduced inflam-
matory cell infiltration (due to apoptosis induction spe-
cific to these cells), decreased expression of MMPs and
pro-inflammatory cytokines TNF-a and IL-8, and
increased expression of anti-inflammatory cytokine IL-4
and epidermal growth factor (EGF), keratinocyte growth
factor (KGF, also known as fibroblast growth factor
(FGF)-7), and KGF-2 (also known as FGF-10). Activity
varied with the conditions under which the silver-con-
taining solutions were generated, but did not correlate
with total silver dissolved.
Methods
Materials
Silver-containing solutions were generated as follows:
Nanocrystalline silver dressings (Acticoat™, Smith and
Nephew PLC, Largo, FL) were added at a ratio of 1 in
2/
mL to the following solutions: distilled water (pH 5.6
solution); distilled water adjusted to a pH of 4 by bub-
bling carbon dioxide through the water (pH 4 solution);
distilled water adjusted to a pH of 7 by adding calcium
hydroxide drop-wise (pH 7 solution); or distilled water
adjusted to a pH of 9 by adding calcium hydroxide
drop-wise (pH 9 solution). Containers were sealed and
dissolution was allowed to proceed for 24 hours at
room temperature under stirring at 100 rpm prior
to use.
Animals
18 young domestic, commercially produced, Large
White/Landrace swine (15-20 kg) were used in this
study. The animals selected were healthy and without
significant wounds or scars on their backs. The animals
were kept in individual pens at the Swine Research and
Technology Centre (Edmonton, AB) with a 12 hour
light/dark cycle, where they were allowed to acclima-
tize seven days prior to starting experiments. Three
animals were used in all experimental groups. The ani-
mals received antibiotic-free water and hog ration ad
libitum during the first three weeks of the experiment.
Rations were limited prior to procedures on Days 0
through 3. The study was approved by the University
of Alberta Animal Policy & Welfare Division of the
Research Ethics Office (formerly Health Sciences Ani-
mal Policy and Welfare Committee) and was conducted
with humane care of the animals in accordance with
guidelines established by the Canadian Council of Ani-
mal Care (CCAC).
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reaction
Inflammation was induced using dinitrochlorobenzene
(DNCB), similar to procedures described in the litera-
ture[1,6,15-17]. On Day -14, the hair on the left side of
the backs of 15 pigs was shaved using electric clippers.
10% DNCB (in 4:1 acetone:olive oil) was painted over
an area of approximately 15 cm × 25 cm on the shaved
portion of the back, which was caudal to the scapula
running over the rib cage and five centimetres off the
dorsal median line. The total body surface area painted
was about 5%, as determined by the equation of Kelley
et al. [18] The volume of DNCB painted per pig was 3
mL on average. This procedure was repeated on Days
- 7 ,- 3 ,a n d0 .O nD a y- 1 ,p i g sw e r eg i v e nt r a n s d e r m a l
fentanyl patches on shaved skin away from the rash, to
avoid discomfort to the pigs during the final application
and treatment. The remaining three pigs, which were
used as negative controls, were left unexposed to
DNCB, but were shaved and received fentanyl patches
on Day -1.
Treatment
Four hours after the final application of DNCB, treat-
ment was commenced with the pigs being placed under
general anaesthetic. On Day 0, visual observations were
made and 4 mm biopsies were obtained towards the
front of the rash (cephalic region), but well within the
border of the rash, to ensure that the biopsies were
taken from areas which had received good DNCB con-
tact. On subsequent days, biopsies were taken in a line
towards the rear of the pig, spaced sufficiently far apart
that the new biopsies would not be affected by the pre-
vious biopsies, and would still be well within the border
of the DNCB-painted area. Calcium alginate dressings
were used to reach haemostasis after biopsies were
taken. The pigs were then treated. Three positive con-
trols (with rashes) and the three negative controls were
treated with distilled water-soaked rayon/polyester
gauze. Three pigs were each treated with gauze soaked
in pH 4, pH 5.6, pH 7, or pH 9 silver-containing solu-
tions which were generated as described above. New
fentanyl patches were applied, if they had come loose.
Surgical drape was placed over each dressing to provide
moisture control, and elastic adhesive dressing was used
to hold the dressings in place. The procedures of Day 0
were repeated on Day 1 and Day 2 (at 24 and 48 h). On
Day 3 (72 h), after visual images, scores, and biopsies
were taken, the pigs were euthanized.
Total Silver Analysis
Samples of nanocrystalline silver derived solutions were
obtained daily at the time of treatment, and submitted
for total silver analysis by atomic absorption spectroscopy
(AAS). For AAS, a Varian 220 FS double beam Atomic
Absorption Spectrophotometer was used, with the follow-
ing instrument parameters: an Ag hollow cathode lamp
with a wavelength of 328.1 nm, and a lean air-acetylene
flame. A calibration plot was generated using silver stan-
dards of 0.5, 1.0, 3.0, and 5.0 ppm, prepared from a silver
standard stock solution of 1000 ppm. If the solutions
contained more than 5 ppm silver, they were diluted as
necessary with distilled water until they were in the linear
range for silver analysis (0.1 ppm to 5 ppm).
Visual observations
Pictures were taken of the rash, with wound rulers
included, on each treatment day. Erythema and oedema
were graded on a scale of 0-4 on Days 0 through 3 (0,
24, 48, and 72 h), using the following scale: 0 - no
erythema or oedema; 1 - barely visible pink, or mildly
raised tissue covering parts of the rash; 2 - moderate
redness, or moderately raised firm tissue covering parts
of the rash; 3 - severe bright red erythema, or obvious
swelling and hardness of tissues over most of the rash; 4
- dark red/purple erythema, or hard raised tissue over
the entire rash.
Histopathology
All samples to be paraffinised were placed in 4% neutral
buffered paraformaldehyde. The samples were then
dehydrated in alcohol and xylene; oriented and
embedded in paraffin; and sectioned (5 μm). For histo-
pathological analysis, sections were stained with haema-
toxylin and eosin following standard procedures[19].
Images were taken of the epidermal-dermal junction (or
the surface of the tissue if there was no clear junction
due to tissue damage caused by the rashes) for each ani-
mal at each time point at 100× magnification using an
optical microscope with an attached digital camera.
Gelatinase zymography
Gelatinase activity was measured similar to the methods
used previously, with some minor modifications[6]. To
extract protein, half of a snap-frozen biopsy from each
animal was homogenized using a Mikro-Dismembrator
(B. Braun Biotech International, Allentown, PA, USA)
for 30 seconds at 2600 rpm. 1 mL of lysis buffer (1%
Triton-X 100, 20% glycerol in phosphate buffered saline
(PBS)) was added to the samples for protein extraction.
Homogenates were centrifuged at 13 000 rpm for 30
minutes at 4°C to remove debris. Total protein concen-
trations were measured with a BCA protein assay
reagent kit (Pierce Biotechnology, Inc., Rockford, IL,
US). Protease activity was then measured using gelatine
zymographs[20], using the same protein concentration
for each sample. To run the zymogram, 12% polyacryla-
mide gels (1.5 mm thick) were cast containing 0.15%
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reducing conditions without heating. After running the
gels, they were rinsed in 2% Triton X-100 on a gyratory
shaker (0.5 h, room temperature), incubated in develop-
ing buffer (50 mM Tris pH 8.0, 0.1 mM CaCl2)o v e r -
night at 37°C, and stained with Coomassie blue. Excess
stain was removed using a destaining solution (50 mL
acetic acid, 200 mL methanol, 250 mL ddH2O). Gelati-
nase activity appears as a clear band (indicative of clea-
vage of the gelatine substrate) on a blue background.
For quantitative analysis, photographs of the gels were
loaded into AlphaImager software (AlphaEase, FC Soft-
ware Version 4.1.0, Alpha Innotech Corporation, San
Leandro, CA, USA © 1993-2004). The integrated density
value (IDV) of each band was measured, holding the
band area constant. Each IDV was then divided by the
IDV of a portion of the gel background of the same
area, to correct for differences in gel densities between
the four gels required to run all the samples.
Apoptosis detection
Detection of the presence of apoptotic cells in tissue
samples after 24 hours of treatment was determined
using the In Situ Cell Death Detection Kit (Roche
Applied Sciences, Basel, Switzerland), as described pre-
viously[6], with modifications. Briefly, paraffinised tissue
samples were dewaxed, rehydrated, and treated with
proteinase K (25 μg/mL) for half an hour at 37°C. Tis-
sues were then incubated at 4°C overnight with fluores-
cein isothiocyanate (FITC)-labelled deoxyribonucleotide
triphosphate (dNTP) and terminal deoxynucleotidyl
transferase (TdT). The tissue samples were mounted
using a polyvinyl alcohol based mounting medium con-
taining 1:1000 4’,6-diamidino-2-phenylindole (DAPI,
provided by the Department of Oncology Cell Imaging
Facility, University of Alberta) for nuclear counterstain-
ing. Sections were imaged using a Zeiss LSM510 multi-
channel laser scanning confocal microscope (Carl Zeiss
MicroImaging GmbH, Oberkochen, Germany) at the
Cell Imaging Facility. Images were taken using the fol-
lowing settings: objective: 40× 1.3; laser for DAPI:
364 nm, 1% power, 444 μm pinhole; and laser for FITC:
488 nm, 4% power, 91 μm pinhole. Images were taken
of the deep dermis and of the epidermal-dermal junc-
tion, which was taken to be either where re-epithelialisa-
tion was occurring or to be the tissue surface, if no re-
epithelialisation was observed in the tissue. Images
selected to represent each group were median images in
terms of their apoptotic staining. Semi-quantitative ana-
lysis was performed using ImageJ software (Rasband,
W., v1.37, NIH, Rockville, MD, USA. © 2007). First, the
epidermis or dermis was manually selected. An AND
function was used to select only apoptotic staining
which was colocalized with nuclear staining, in order to
eliminate any background staining. The same thresholds
were used for all samples, since they were stained and
imaged under identical conditions. Total numbers of
green (apoptotic staining) and blue (nuclear staining)
pixels were counted, and a ratio of green to blue pixels
was calculated to obtain a relative measure of apoptotic
activity. Images in which apoptotic staining did not
coincide with nuclear staining were excluded.
Immunohistochemistry
Tissue samples after 24 h and 72 h of treatment were
analyzed for the presence of TNF-a,I L - 4 ,I L - 8 ,I L - 1 0 ,
EGF, KGF (FGF-7), and KGF-2 (FGF-10), as described
previously[7]. Briefly, paraffinised samples were dewaxed
and rehydrated. To improve antigen retrieval, samples
tested for TNF-a, IL-8, and KGF were incubated in 25
μg/mL proteinase K at 37°C for 20 minutes. All samples
were then treated with 3% H2O2 for 30 minutes to
quench endogenous peroxidase activity, and then
blocked for one hour with the sera from the species that
the secondary antibody was raised in (rabbit for KGF,
KGF-2, and IL-4; goat for TNF-a, IL-8, IL-10, and
EGF). Sections were then incubated overnight at 4°C
with 5 μg/mL of the appropriate antibody: mouse-anti-
pTNF-a (MP390, Endogen, Fisher Scientific Inc.,
Ottawa, Ontario, Canada), mouse-anti-pIL-8 antibody
(MP800, Endogen), goat-anti-pIL-4 (AF654, R&D
Systems, Minneapolis, MN, USA), mouse-anti-
hEGF (MAB236, R&D Systems), mouse-anti-pIL-10
(MAB6932, R&D Systems), goat-anti-hFGF-7 (KGF, AF-
251-NA, R&D Systems), or goat-anti-hFGF-10 (KGF-2,
AF345, R&D Systems). For sections incubated with pri-
mary antibodies produced in mouse, negative control
tissues were incubated with 5 μg/mL mouse IgG during
this step. These sections were subsequently incubated
with goat-anti-mouse-HRP (horseradish peroxidase -
R&D Systems, 1:400 in 2% pig serum) for one hour. For
sections incubated with primary antibodies produced in
goat, negative control tissues were incubated with PBS
during the primary antibody incubation step. These sec-
tions were then incubated with rabbit-anti-goat-HRP
(R&D Systems, 1:400 in 2% pig serum). All tissues were
then stained using 3,3’-diaminobenzidine (DAB) and
H2O2 (25 mg DAB, 50 μLH 2O2 in 50 mL PBS). Sam-
ples were then counterstained with haematoxylin (30
seconds), dehydrated, and mounted using Permount™
mounting solution. Images of the samples were taken as
described for histology. Samples stained for one cytokine
were run in three batches of twelve slides under identi-
cal conditions. Each batch contained samples from all
treatment groups. Therefore, the intensity of staining
can be used as a qualitative indication of the relative
quantity of cytokines present in the tissues. Intensity of
staining was scored on a scale from 0 to 4 as follows: 0
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and/or very light staining; 2 - small areas of dark stain-
ing and/or larger areas of light staining; 3 - diffuse light
staining and/or larger areas of dark staining, 4 - diffuse
dark staining.
Statistics
Tests were performed on all three pigs from each group
to confirm result reproducibility. For numerical results,
one-way ANOVAs with Tukey-Kramer Multiple Com-
parisons post tests were performed using GraphPad
InStat version 3.06 (GraphPad Software, San Diego,
California, USA, http://www.graphpad.com, © 2003) for
normally distributed data. For data which was not nor-
mally distributed (apoptotic staining data), Kruskal-
Wallis Tests (non-parametric ANOVAs) were performed
with Dunn’s Multiple Comparisons post-test, also using
GraphPad InStat. Standard deviations are plotted as
error bars for all data points. For some data points, the
standard deviation was very small.
Results
Visual observations
Figure 1 shows representative digital images of a nega-
tive control (A), a DNCB induced rash just prior to
commencing treatment (B), a positive control (rash
treated with distilled water) after 72 hours of treatment
(C), and animals with rashes treated for 72 hours with
pH 4 (D), 5.6 (E), 7 (F), and 9 (G) silver-containing
solutions. Animals treated with pH 7 and 9 solutions
showed the most improvement during treatment, with
decreased redness and swelling around the rash edges,
and areas where the scabbing had fallen off, revealing
healthy tissue underneath. Animals treated with pH 4
and 5.6 solutions showed some improvement during
treatment, with decreased redness around the edges of
the rash. However, the scabbing mostly stayed in place
for these treatment groups. Positive controls showed
little improvement over 72 hours, with a full scab
across the rash, and redness and swelling around
the scab.
Figure 1 Digital images of DNCB-induced rashes treated with various nanocrystalline silver-derived solutions.R e p r e s e n t a t i v ed i g i t a l
images are shown for (A) negative controls (pigs which received no rash, and were treated with distilled water-soaked dressings); (B) DNCB-
induced rashes on Day 0 before treatment was commenced; (C) positive controls (pigs which had DNCB-induced rashes and were treated with
distilled water) after 72 hours of treatment; and animals treated for 72 hours with nanocrystalline silver-derived solutions with starting pHs of
(D) 4, (E) 5.6, (F) 7, and (G) 9.
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treated with various nanocrystalline silver-derived solu-
tions relative to positive and negative controls. From 48
hours of treatment on, animals treated with pH 9 solu-
tions had significantly lower erythema scores relative to
positive controls and animals treated with pH 4 and pH
5.6 solutions (see Table 1). Figure 2B shows the average
oedema scores for pigs treated with various nanocrystal-
line silver-derived solutions, again relative to positive
and negative controls. After 48 hours of treatment, ani-
mals treated with pH 4, 7, or 9 solutions had signifi-
cantly lower oedema scores relative to positive controls
or to animals treated with pH 5.6 solutions. After 72
hours of treatment, animals treated with pH 9 solutions
had significantly lower oedema scores relative to positive
controls and to animals treated with pH 4 solutions (see
Table 1).
Figure 2 Erythema and oedema scores for DNCB-induced
rashes treated with various nanocrystalline silver-derived
solutions. Daily average erythema and oedema scores are shown in
Panels A and B, respectively, for negative controls (pigs without
rashes treated with distilled water-soaked dressings), and for pigs
with DNCB-induced contact dermatitis treated for three days with
distilled water (positive controls) or nanocrystalline silver-derived
solutions with starting pHs of 4, 5.6, 7, or 9. The statistical analyses,
which were performed using one-way ANOVAs with Tukey-Kramer
Multiple Comparisons post tests, are shown in Table 1. Error bars
represent standard deviations.
Table 1 Statistical analysis of erythema and oedema
scores*.
Assay Time
(h)
ANOVA Post Test Results
Erythema 0 p < 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.001)
Negative control < pH 9 (p < 0.001)
Erythema 24 p = 0.0018 Negative control < Positive Control
(p < 0.01)
Negative control < pH 4 (p < 0.05)
Negative control < pH 5.6 (p < 0.01)
Negative control < pH 7 (p < 0.05)
Erythema 48 p < 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.001)
Negative control < pH 9 (p < 0.001)
pH 9 < Positive Control (p < 0.01)
pH 9 < pH 4 (p < 0.05)
pH 9 < pH 5.6 (p < 0.01)
Erythema 72 p < 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.001)
pH 9 < Positive Control (p < 0.01)
pH 9 < pH 4 (p < 0.05)
pH 9 < pH 5.6 (p < 0.05)
Oedema 0 p < 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.001)
Negative control < pH 9 (p < 0.001)
Oedema 24 p = 0.0007 Negative control < Positive Control
(p < 0.01)
Negative control < pH 4 (p < 0.01)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.01)
Negative control < pH 9 (p < 0.01)
Oedema 48 p < 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p <
0.001)
Negative control < pH 7 (p < 0.001)
Negative control < pH 9 (p < 0.001)
pH 4 < Positive Control (p < 0.05)
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Representative histological images over the course of
treatment are shown in Figure 3. Before treatment
(column 1), tissues from all DNCB-challenged animals
demonstrated leukocyte and red blood cell infiltration,
with epidermal disruption due to excessive oedema.
Negative controls (A-D) showed normal tissue morphol-
ogy throughout the study, with a well-defined epidermis,
and low cellularity in the dermis. Positive controls (E-H)
showed no improvement over the course of treatment,
with extensive infiltration of inflammatory cells through-
out the experiment. Animals treated with pH 4 solutions
(I-L) showed a gradual reduction of inflammatory cells
over the course of treatment, with re-epithelialisation
beginning to occur by 48 hours of treatment. Animals
treated with pH 5.6 solutions (M-P) did not show histo-
logical signs of improvement until 72 hours of treat-
ment, at which point decreased inflammatory cells were
present, and re-epithelialisation began. Animals treated
with pH 7 solutions (Q-T) had begun re-epithelialisation
at 48 hours, and showed lower leukocyte infiltration at
72 hours than animals treated with pH 4 solutions.
However, the re-epithelialisation that occurred appeared
to be thicker with deeper ridges. Animals treated with
pH 9 solutions (U-X) all showed signs of re-epitheliali-
sation at 48 hours of treatment, with one animal even
showing signs of re-epithelialisation at 24 hours (not
shown). At 72 hours, the animals treated with pH 9
solutions showed the best overall tissue morphology,
including the most well-defined epidermis and dermis,
clearest dermal morphology, and lowest leukocyte
infiltration.
Zymography for gelatinases
Figure 4 shows zymograms for all pigs in each treatment
and control group after 24 (A) and 72 (B) hours of
treatment. Throughout treatment, negative controls
visually showed very low levels of gelatinases. After 72
hours of treatment, positive controls and pH 4 solution
treated animals had two animals out of three showing
high gelatinase levels, while animals treated with pH 5.6,
7, and 9 solutions had only one animal out of three
showing high gelatinase levels. Figure 4C shows the
semi-quantitative analysis of proMMP-9 (pMMP-9)
levels, which showed a trend towards significant differ-
ences between groups (p = 0.0817), with pMMP-9 levels
being lower for pH 5.6, 7, and 9 treatments relative to
positive controls and pH 4 treatments (see Table 2 for
statistical analysis). All treatment groups showed similar
levels at 72 hours. Figure 4D shows the semi-quantita-
tive analysis of active MMP-9 (aMMP-9) levels. Again,
there was a trend towards significant differences
between groups (p = 0.0944), with lower expression
levels at 24 h for silver treated animals relative to posi-
tive controls, particularly with treatments at pH 5.6, 7,
and 9. Panel 4E shows the semi-quantitative analysis for
pMMP-2, which showed significant differences between
groups (p = 0.0010), with pH 5.6 and 9 treated animals
having significantly lower pMMP-2 levels relative to
positive controls after 24 hours of treatment (see Table
2). Panel 4F shows the semi-quantitative analysis for
aMMP-2, which also showed significant differences
between groups (p = 0.0019), with pH 9 solution treated
animals showing significantly lower aMMP-2 levels at
24 hours relative to positive controls and pH 4 solution
treated animals (see Table 2).
Apoptosis detection
Figure 5 shows representative images of staining for
apoptotic cells after 24 hours of various treatments.
Figure 6 shows a semi-quantitative analysis of apoptotic
staining in the epidermis (A), superficial dermis (B),
deep dermis (C), and total dermis (D). Table 3 shows
statistical analysis of these results. Negative controls
(Figure 5A) had very few apoptotic cells. Positive con-
trols showed somewhat higher levels of apoptosis in the
epidermis (Figure 5B), but had decreasing levels of
apoptosis with tissue depth, with virtually no cells
undergoing apoptosis in the deep dermis (Figure 5C,
6C). Animals treated with pH 4 solutions had somewhat
lower levels of apoptosis induction in the epidermis rela-
tive to positive controls, with similar levels present in
the superficial dermis (Figure 5D, 6A-B). However, they
demonstrated the highest level of apoptotic cells in the
deep dermis (Figure 5E, 6C), with levels significantly
higher than negative controls. Animals treated with pH
5.6 solutions did not demonstrate apoptosis induction in
Table 1: Statistical analysis of erythema and oedema
scores*. (Continued)
pH 7 < Positive Control (p < 0.01)
pH 9 < Positive Control (p < 0.001)
pH 4 < pH 5.6 (p < 0.05)
pH 7 < pH 5.6 (p < 0.01)
pH 9 < pH 5.6 (p < 0.001)
Oedema 72 p = 0.0001 Negative control < Positive Control
(p < 0.001)
Negative control < pH 4 (p < 0.001)
Negative control < pH 5.6 (p < 0.01)
Negative control < pH 7 (p < 0.05)
pH 9 < Positive Control (p < 0.01)
pH 9 < pH 4 (p < 0.05)
*Statistical analyses were performed using one-way ANOVAs with Tukey-
Kramer Multiple Comparisons Post Tests. All treatment groups were compared
in an ANOVA, and if the ANOVA indicated significant differences were present
between groups, each treatment group was compared to every other
treatment group in post testing. Only statistically significant post test results
are shown. Any treatment group comparisons not listed were not significantly
different from one another (p > 0.05).
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Page 7 of 20Figure 3 Representative histological images for DNCB-induced rashes treated with various nanocrystalline silver-derived solutions.
Representative images, including portions of both the epidermis and the dermis, are shown at 0, 24, 48, and 72 h for negative controls (pigs
which did not have rashes and were treated with distilled water-soaked gauze) (A-D), positive controls (pigs which had DNCB-induced rashes
which were treated with distilled water-soaked gauze) (E-H), and animals with DNCB-induced rashes treated with nanocrystalline silver-derived
solutions generated at starting pHs of 4 (I-L), 5.6 (M-P), 7 (Q-T), or 9 (U-X). Cell nuclei were stained purple with haematoxylin, while cytoplasm
was stained pink with eosin. The scale bar in A represents 100 μm.
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Page 8 of 20Figure 4 Gelatinase activity in biopsies from DNCB-induced rashes treated with various nanocrystalline silver-derived solutions.
Zymograms are shown for all three animals of each treatment group at 24 (A) and 72 (B) hours in the following order for each time period:
negative controls (no rash, treated with distilled water), positive controls (had DNCB-induced rash, treated with distilled water), and animals with
DNCB-induced rashes that were treated with nanocrystalline silver-derived solutions generated at starting pHs of 4, 5.6, 7, and 9. Protein ladders
were run as the first sample on each gel. The gels testing biopsies from 24 hours were run simultaneously, as were the gels testing 72 hour
biopsies. The integrated density values (IDV) relative to the gel background IDV for pMMP-9, aMMP-9, pMMP-2, and aMMP-2 are shown in Panels
C, D, E, and F, respectively. The statistical analyses, which were performed using one-way ANOVAs with Tukey-Kramer Multiple Comparisons Post
Tests, are shown in Table 2. Error bars represent standard deviations.
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Page 9 of 20either the epidermis (Figure 5F, 6A) or the dermis
(Figure 5G, 6B-D). Animals treated with pH 7 solutions
showed the highest levels of apoptotic cells in the upper
dermis, with significantly higher staining than negative
controls (Figure 6B), and in the epidermis as well
(Figure 5H), although this did not reach statistical signifi-
cance due to high interanimal variability (Figure 6A).
Apoptotic staining was also present to a lesser extent in
the deep dermis (Figure 5I, 6C). Animals treated with pH
9 solutions did not show apoptotic staining in the newly
forming epidermis (Figure 5J, 6A), but did have apoptotic
cells in the dermis, although to a lesser extent than pre-
sent in the pH 4 and 7 treated animals (Figure 5K, 6B-
C). Combining the superficial and deep dermal semi-
quantitative staining results, animals treated with pH 4
solutions had significantly higher apoptotic staining than
negative controls, positive controls, and pH 5.6 solution-
treated animals, while animals treated with pH 7 solu-
tions had significantly higher apoptotic staining relative
to negative controls and pH 5.6 solution-treated animals
(Figure 6D).
Immunohistochemistry
Figure 7 shows an example of the immunohistochemical
images obtained in Panel (A): Representative images of
immunohistochemical staining for TNF-a after 72 hours
of treatment are shown. Immunohistochemical staining
scores are shown after 24 h and 72 hours of treatment
in Panels (B) and (C), respectively. Table 4 shows statis-
tical analysis of the staining scores for all cytokines and
growth factors analyzed. Negative controls showed some
staining in the epidermis throughout the experiment,
but otherwise had low TNF-a levels. Positive controls
showed widespread TNF-a staining, which increased in
intensity during the treatment period. Of the treatment
groups, animals treated with pH 7 solutions showed the
strongest staining for TNF-a at 24 hours, however this
trend did not reach significance. At 72 hours, staining
for TNF-a was somewhat increased with pH 4 and pH
5.6 treatments, particularly in the newly forming epider-
mis, but not to the levels observed in positive controls.
In particular, pH 5.6 treated animals still had signifi-
cantly lower scores than positive controls (p < 0.05).
TNF-a staining appeared to decrease with increasing
pH of treatment at 72 hours, with animals treated with
pH 7 and 9 solutions having significantly lower staining
scores for TNF-a relative to positive controls (p < 0.01)
and pH 4 treated animals (p < 0.05) (see Table 4).
Figure 8 shows immunohistochemical staining scores
for IL-8 after 24 and 72 hours of treatment in Panels
(A) and (B), respectively. As with TNF-a, negative con-
trols showed some staining for IL-8 in the epidermis,
but low levels in the dermis throughout the experiment.
Positive controls, and pH 5.6 and 7 solution-treated ani-
mals, showed mild increases in IL-8 staining relative to
negative controls at 24 hours, while pH 4 and 9 treated
animals showed lower levels of staining. However, this
trend did not reach significance (see Table 4). At 72
hours, positive controls showed strong staining for IL-8
throughout the epidermis and in a cell-associated fash-
ion in the dermis. Animals treated with pH 4, 5.6, and 7
solutions showed low staining for IL-8 at this time
point, with the pH 5.6 solution treated animals having
significantly lower staining scores relative to the positive
controls (p < 0.05). Interestingly, animals treated with
pH 9 solutions showed stronger staining for IL-8 in the
epidermis at 72 hours, although this was not as dark as
the staining present in the positive controls.
Figure 9 shows immunohistochemical staining scores
for IL-4 after 24 and 72 hours of treatment in Panels
(A) and (B), respectively. Negative controls showed low
levels of staining for IL-4 throughout the study, with
only mild cell-specific staining in the dermis. Positive
controls and animals treated with pH 4, 5.6, and 7 solu-
tions showed low levels of widespread staining at 24
hours of treatment. However, animals treated with pH 9
solutions showed stronger staining at 24 hours of treat-
ment. This was the only treatment group to have signifi-
cantly stronger staining than the negative controls at 24
hours (p < 0.05, see Table 4). At 72 hours of treatment,
mild increases in IL-4 staining were observed in some
keratinocytes of the positive controls and pH 4 treated
solutions, with the pH 4 treated solutions having signi-
ficantly stronger staining than the negative controls
Table 2 Statistical analysis of gelatinase activity*.
MMP ANOVA Post Test Results
pMMP-9 p = 0.0817 No significant differences.
aMMP-9 p = 0.0944 No significant differences.
pMMP-2 p = 0.0010 pH 5.6 (24 h) < Positive Control (24 h) (p < 0.05)
pH 9 (24 h) < Positive Control (24 h) (p < 0.01)
Negative Control (72 h) < Positive Control (24 h)
(p < 0.001)
Positive Control (72 h) < Positive Control (24 h)
(p < 0.05)
pH 4 (72 h) < Positive Control (24 h) (p < 0.05)
pH 5.6 (72 h) < Positive Control (24 h) (p < 0.05)
Negative Control (72 h) < pH 4 (24 h) (p < 0.05)
aMMP-2 p = 0.0019 pH 9 (24 h) < Positive Control (24 h) (p < 0.01)
pH 9 (24 h) < pH 4 (24 h) (p < 0.05)
Negative Control (72 h) < Positive Control (24 h)
(p < 0.01)
Negative Control (72 h) < pH 4 (24 h) (p < 0.05)
* Statistical analyses were performed using one-way ANOVAs with Tukey-
Kramer Multiple Comparisons Post Tests. All treatment groups were compared
in an ANOVA, and if the ANOVA indicated significant differences were present
between groups, each treatment group was compared to every other
treatment group in post testing. Only statistically significant post test results
are shown. Any treatment group comparisons not listed were not significantly
different from one another (p > 0.05).
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Page 10 of 20(p < 0.05). Strong staining was observed in the keratino-
cytes throughout the newly re-epithelialised tissues
which had been treated with pH 5.6, 7, and 9 solutions.
In these tissues, cell-associated staining was also
observed in the dermis, most likely in fibroblasts. These
tissues all had significantly stronger staining than nega-
tive controls (p < 0.01).
Figure 10 shows immunohistochemical staining scores
for EGF after 24 and 72 hours of treatment in Panels
(A) and (B), respectively. Negative controls showed low
staining for EGF throughout the experiment, with some
cell specific staining present in the dermis. Positive
controls showed mild widespread staining for EGF at 24
h, while pH 4 and pH 7 solution treatments resulted in
low levels of staining, which was present in areas of tis-
sue damage. Animals treated with pH 5.6 solutions
showed somewhat stronger staining, both in the
damaged epidermis and in the dermis where re-epithe-
lialisation would later take place. Animals treated with
pH 9 solutions showed staining in the damaged epider-
mis, but much stronger cell associated staining in the
newly forming epidermis. This staining was significantly
stronger than all other groups except the pH 5.6 solu-
tion treated animals (see Table 4). At 72 hours, all
Figure 5 Apoptosis detection in biopsies of DNCB-induced rashes treated for 24 h with various nanocrystalline silver-derived
solutions. Representative fluorescence images obtained via confocal microscopy for immunohistochemical detection of apoptotic cells in pigs
with DNCB-induced rashes after 24 h of various treatments are shown. The first column shows staining by FITC for apoptotic cells (green). The
second column shows counterstaining by DAPI for nuclei (blue). The third column shows the combination of apoptotic and nuclear staining.
Images in Row A are from the surface (epidermis and upper dermis) of a negative control (no rash) treated with distilled water. Images in Rows
B and C are of the skin surface and deep dermis, respectively, of a positive control (rash treated with distilled water). Images in Rows D and E
are of the surface and the deep dermis, respectively, of a DNCB-induced porcine rash treated with a nanocrystalline silver-derived solution with a
starting pH of 4. Images in Rows F and G are of the surface and the deep dermis, respectively, of a DNCB-induced porcine rash treated with a
nanocrystalline silver-derived solution with a starting pH of 5.6. Images in Rows H and I are of the surface and the deep dermis, respectively, of a
DNCB-induced porcine rash treated with a nanocrystalline silver-derived solution with a starting pH of 7. Images in Rows J and K are of the
surface and the deep dermis, respectively, of a DNCB-induced porcine rash treated with a nanocrystalline silver-derived solution with a starting
pH of 9. The scale bar in the far right image in Row A represents 20 μm.
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Page 11 of 20treatment groups, but especially those animals treated
with pH 5.6 or higher, showed strong EGF staining in
keratinocytes of the newly formed epidermis, as well as
some staining in the dermis associated with cells that
are most likely fibroblasts. Positive controls continued
to show only low levels of widespread staining. While
ANOVA testing indicated that there were significant dif-
ferences between groups, the post tests did not identify
differences between individual groups (see Table 4).
Figure 11 shows immunohistochemical staining scores
for KGF after 24 and 72 hours of treatment in Panels (A)
and (B), respectively. Negative controls showed similar
levels of staining for KGF in the epidermis throughout the
study. Positive controls showed low staining for KGF at 24
hours, as did pH 4 and 7 solution-treated animals. Ani-
mals treated with pH 5.6 and 9 solutions showed strongly
Figure 6 Semi-quantitative analysis of apoptosis in DNCB-induced rashes treated for 24 h with nanocrystalline silver-derived solutions.
Semi-quantitative analysis of apoptotic staining in biopsies from pigs with DNCB-induced rashes after 24 h of various treatments is shown. The
relative apoptotic staining level was calculated by taking a ratio of apoptotic staining (where colocalized with nuclear staining) to total nuclear
staining in a given image window. Semi-quantitative analysis of staining in the epidermis, superficial dermis, deep dermis, and all dermal images
combined are shown in (A) through (D), respectively. Statistical analysis, which was performed using Kruskal Wallis testing with Dunn’s Multiple
Comparisons post testing, is provided in Table 3. Error bars represent standard deviations.
Table 3 Statistical analysis of apoptotic staining*.
Skin Layer Kruskal-Wallis Post Test Results
Epidermis p = 0.0673 No significant differences.
Superficial Dermis p = 0.0433 Negative Control < pH 7 (p < 0.05)
Deep Dermis p = 0.0055 Negative Control < pH 4 (p < 0.05)
Whole Dermis p < 0.0001 Positive Control < pH 4 (p < 0.05)
Negative Control < pH 4 (p < 0.05)
pH 5.6 < pH 4 (p < 0.01)
Negative Control < pH 7 (p < 0.05)
pH 5.6 < pH 7 (p < 0.05)
*Statistical analyses were performed using Kruskal Wallis tests with Dunn’s
Multiple Comparisons Post Tests. All treatment groups were compared in a
Kruskal Wallis test, and if that indicated significant differences were present
between groups, each treatment group was compared to every other
treatment group in post testing. Only statistically significant post test results
are shown. Any treatment group comparisons not listed were not significantly
different from one another (p > 0.05).
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Page 12 of 20increased staining, particularly in the epidermis. Animals
treated with pH 5.6 solutions had significantly stronger
staining than animals treated with pH 7 solutions (p <
0.05), while animals treated with pH 9 solutions had signifi-
cantly stronger staining than all other groups except ani-
mals treated with pH 5.6 solutions (p < 0.05, see Table 4).
By 72 hours, differences in tissue staining appeared to level
out, with medium-strength cell-specific staining occurring
in the epidermis of the positive controls and all treatment
groups. No significant differences were found at this time
point (see Table 4).
Figure 12 shows another example of the immunohisto-
chemical images obtained: Representative images of
immunohistochemical staining for KGF-2 after 24 hours
of treatment are shown in Panel (A). Immunohistochem-
ical staining scores for KGF-2 after 24 and 72 hours of
treatment are shown in Panels (B) and (C), respectively.
Negative controls showed some cell-specific staining for
KGF-2 in the epidermis and dermis at 24 hours, but
minimal staining at 72 hours. Positive controls showed
low levels of widespread staining throughout the study.
At 24 hours, animals treated with pH 4 and 5.6 solutions
showed low levels of staining for KGF-2 near tissue sur-
faces, while animals treated with pH 7 solutions showed
minimal staining for KGF-2. Animals treated with pH 9
Figure 7 Immunohistochemical detection of TNF-a in biopsies
of DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. (A) Representative images are shown for
immunohistochemical detection of TNF-a after 72 h treatment of
negative controls with distilled water (i), and DNCB-induced porcine
contact dermatitis rashes with distilled water (positive controls) (ii),
or nanocrystalline silver-derived solutions generated at starting pHs
of 4 (iii), 5.6 (iv), 7 (v), or 9 (vi). The scale bar in A represents 100
μm. Staining for TNF-a appears brown, while the cell nuclei are
counterstained purple using haematoxylin. Immunohistochemical
staining scores for TNF-a are shown after 24 h (B) and 72 h (C) of
treatment as described above. Statistical analyses, which were
performed using one-way ANOVAs with Tukey-Kramer Multiple
Comparisons post tests, are shown in Table 4. Error bars represent
standard deviations.
Table 4 Statistical analysis of immunohistochemical
staining scores*.
Cytokine/
Growth
Factor
Time
(h)
ANOVA Post Test Results
TNF-a 24 h p = 0.3582 No significant differences.
TNF-a 72 h p = 0.0004 pH 7 < pH 4 (p < 0.05)
pH 9 < pH 4 (p < 0.05)
pH 7 < Positive Control (p < 0.01)
pH 9 < Positive Control (p < 0.01)
Negative Control < Positive Control
(p < 0.05)
IL-8 24 h p = 0.1742 No significant differences.
IL-8 72 h p = 0.0492 pH 5.6 < Positive Control (p < 0.05)
IL-4 24 h p = 0.0248 Negative Control < pH 9 (p < 0.05)
IL-4 72 h p = 0.0026 Negative Control < pH 4 (p < 0.05)
Negative Control < pH 5.6 (p < 0.01)
Negative Control < pH 7 (p < 0.01)
Negative Control < pH 9 (p < 0.01)
EGF 24 h p = 0.0031 Negative Control < pH 9 (p < 0.01)
Positive Control < pH 9 (p < 0.05)
pH 4 < pH 9 (p < 0.01)
pH 7 < pH 9 (p < 0.01)
EGF 72 h p = 0.0199 No significant differences.
KGF 24 h p = 0.0039 Negative Control < pH 9 (p < 0.05)
Positive Control < pH 9 (p < 0.05)
pH 4 < pH 9 (p < 0.05)
pH 7 < pH 9 (p < 0.05)
pH 7 < pH 5.6 (p < 0.05)
KGF 72 h p = 0.1310 No significant differences.
KGF-2 24 h p = 0.0105 pH 7 < pH 9 (p < 0.05)
Negative Control < pH 9 (p < 0.05)
KGF-2 72 h p = 0.0173 Negative Control < pH 5.6 (p < 0.05)
Negative Control < pH 7 (p < 0.05)
IL-10 24 h p = 0.6472 No significant differences.
IL-10 72 h p = 0.8397 No significant differences.
*Statistical analyses were performed using one-way ANOVAs with Tukey-
Kramer Multiple Comparisons Post Tests. All treatment groups were compared
in an ANOVA, and if the ANOVA indicated significant differences were present
between groups, each treatment group was compared to every other
treatment group in post testing. Only statistically significant post test results
are shown. Any treatment group comparisons not listed were not significantly
different from one another (p > 0.05).
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Page 13 of 20solutions showed strong cell-associated staining for KGF-
2, particularly in the keratinocytes of the newly forming
epidermis, but also to a lesser extent in the dermis, per-
haps in fibroblasts. This staining was significantly higher
than that in negative controls or pH 7 solution treated
animals (p < 0.05). At 72 hours, all animals receiving sil-
ver-containing treatments showed this type of strong cell-
associated staining. In animals treated with pH 5.6 or 7
solutions, the staining was significantly stronger than that
seen in the negative controls (p < 0.05, see Table 4).
Immunohistochemical analysis of IL-10 did not show
strong staining in any of the groups tested at any time
point (see Figure 13), and there were no significant dif-
ferences between groups (see Table 4), although staining
was present around blood vessels.
Average Silver and Calcium Delivered
The average daily total of silver delivered via the nano-
crystalline silver-derived solutions to each treatment
group was as follows: 1.88 ± 0.59 mg (pH 4), 0.28 ±
0.11 mg (pH 5.6), 0.20 ± 0.08 mg (pH 7), 0.27 ± 0.15
mg (pH 9). There were significant differences between
treatment groups (p = 0.0011), with animals in the pH 4
solution treatment group receiving significantly higher
(p < 0.01) total silver per day than all other groups.
There were no significant differences in silver delivered
to the remaining groups. Based on the quantities of Ca
(OH)2 used to generate solutions, and the volumes
delivered per day to the animals, animals in the pH 7
and pH 9 solution groups received approximately 0.004
mg and 0.019 mg Ca
+ per day, respectively.
Discussion
In this study, contact dermatitis was induced using
DNCB in a porcine model. This is a well-established
model of inflammation, since DNCB-induced dermatitis
is the prototype of T-cell mediated delayed-type hyper-
sensitivity reactions[1,2,21]. It is also a clinically relevant
Figure 8 Immunohistochemical detection of IL-8 in biopsies of
DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. Immunohistochemical staining scores for
IL-8 are shown after 24 h (A) and 72 h (B) of treatment of negative
controls with distilled water, and DNCB-induced porcine contact
dermatitis rashes with distilled water (positive controls), or
nanocrystalline silver-derived solutions generated at starting pHs of
4, 5.6, 7, or 9. Statistical analyses, which were performed using one-
way ANOVAs with Tukey-Kramer Multiple Comparisons post tests,
are shown in Table 4. Error bars represent standard deviations.
Figure 9 Immunohistochemical detection of IL-4 in biopsies of
DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. Immunohistochemical staining scores for
IL-4 are shown after 24 h (A) and 72 h (B) of treatment of negative
controls with distilled water, and DNCB-induced porcine contact
dermatitis rashes with distilled water (positive controls), or
nanocrystalline silver-derived solutions generated at starting pHs of
4, 5.6, 7, or 9. Statistical analyses, which were performed using one-
way ANOVAs with Tukey-Kramer Multiple Comparisons post tests,
are shown in Table 4. Error bars represent standard deviations.
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Page 14 of 20model, due to the similarities between porcine and
human skin[22-24]. Consistent strong inflammation was
observed at Day 0 in this study. Negative controls did
not appear to be impacted by treatment with distilled
water, while positive controls did not show signs of
improvement over 72 hours.
This study shows that solutions derived from nano-
crystalline silver have some or all of the anti-inflamma-
tory properties of nanocrystalline silver dressings
previously reported[2,3,6,7], depending on dissolution
conditions. Nanocrystalline silver-derived solutions were
able to reduce visual and histological signs of inflamma-
tion. This occurred in conjunction with induction of
apoptosis in infiltrating inflammatory cells. Apoptosis of
these cells may have led to the observed reduction in
expression of TNF-a and IL-8, which are both key med-
iators of the inflammatory response[25,26]. Apoptosis is
involved with eliminating inflammatory cells from
inflamed tissues[25], and compounds which induce
apoptosis, including noble metals[11-14,27-29], are ben-
eficial in the treatment of inflammatory diseases. Thus,
induction of apoptosis in inflammatory cells by nano-
crystalline silver-derived solutions appears to be a key
factor for their anti-inflammatory activity. Apoptosis
induction may have, in part, been regulated by the
observed increased expression of IL-4, an anti-inflamma-
tory cytokine which induces apoptosis of neutrophils
and macrophages, and downregulates the effects of IL-1,
TNF-a, IL-6, and IL-8 on macrophages[30-33]. IL-10
did not appear to be involved in the anti-inflammatory
effect seen. This was also observed previously in a study
using nanocrystalline silver dressings[7], but differs from
a study using silver nanoparticles to treat murine ther-
mal injuries[34]. As with nanocrystalline silver dressings
[7], upregulation of EGF, KGF, and KGF-2 was observed
with nanocrystalline silver-derived treatments. EGF
Figure 10 Immunohistochemical detection of EGF in biopsies
of DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. Immunohistochemical staining scores for
EGF are shown after 24 h (A) and 72 h (B) of treatment of negative
controls with distilled water, and DNCB-induced porcine contact
dermatitis rashes with distilled water (positive controls), or
nanocrystalline silver-derived solutions generated at starting pHs of
4, 5.6, 7, or 9. Statistical analyses, which were performed using one-
way ANOVAs with Tukey-Kramer Multiple Comparisons post tests,
are shown in Table 4. Error bars represent standard deviations.
Figure 11 Immunohistochemical detection of KGF in biopsies
of DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. Immunohistochemical staining scores for
KGF are shown after 24 h (A) and 72 h (B) of treatment of negative
controls with distilled water, and DNCB-induced porcine contact
dermatitis rashes with distilled water (positive controls), or
nanocrystalline silver-derived solutions generated at starting pHs of
4, 5.6, 7, or 9. Statistical analyses, which were performed using one-
way ANOVAs with Tukey-Kramer Multiple Comparisons post tests,
are shown in Table 4. Error bars represent standard deviations.
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Page 15 of 20promotes keratinocyte migration, enhancing re-epithelia-
lisation[35-37]; enhances formation of granulation tissue;
and stimulates fibroblast motility[38]. KGF and KGF-2
both stimulate proliferation and migration of keratino-
cytes; promote detoxification of reactive oxygen species
(ROS), protecting keratinocytes from ROS-induced
apoptosis[37,39]; and are involved indirectly with granu-
lation tissue formation[39,40]. Thus, upregulation of
these growth factors may partially explain the enhanced
re-epithelialisation rates and pro-healing activity
observed with nanocrystalline silver-derived solutions.
Solutions generated at a starting pH of 4 showed only
mild visual improvements, with the only significant
reduction in oedema relative to positive controls occur-
ring at 48 h. However, histology showed that re-epithe-
lialisation began to occur within two days of treatment,
and that there was reduced inflammatory cell infiltration
after this time point. There were no significant trends
related to MMP expression or activity. At 24 hours,
apoptosis did not appear to be induced at tissue sur-
faces. However, deeper in the dermis (which is normally
near-acellular but which had been infiltrated by inflam-
matory cells) large numbers of apoptotic cells were
observed, with visible blebbing. Since apoptosis levels
were no higher than those observed in positive controls
in the epidermis, this suggests that very little Ag
+ was
present in the solutions delivered to the animals, as pre-
vious studies have suggested that Ag
+ produces indiscri-
minate apoptosis induction near tissue surfaces[6]. This
suggests that, since there was high total silver in
Figure 12 Immunohistochemical detection of KGF-2 in biopsies
of DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. (A) Representative images are shown for
immunohistochemical detection of KGF-2 after 24 h treatment of
negative controls with distilled water (i), and DNCB-induced porcine
contact dermatitis rashes with distilled water (positive controls) (ii),
or nanocrystalline silver-derived solutions generated at starting pHs
of 4 (iii), 5.6 (iv), 7 (v), or 9 (vi). The scale bar in A represents 100
μm. Staining for KGF-2 appears brown, while the cell nuclei are
counterstained purple using haematoxylin. Immunohistochemical
staining scores for KGF-2 are shown after 24 h (B) and 72 h (C) of
treatment as described above. Statistical analyses, which were
performed using one-way ANOVAs with Tukey-Kramer Multiple
Comparisons post tests, are shown in Table 4. Error bars represent
standard deviations.
Figure 13 Immunohistochemical detection of IL-10 in biopsies
of DNCB-induced rashes treated with various nanocrystalline
silver-derived solutions. Immunohistochemical staining scores for
IL-10 are shown after 24 h (A) and 72 h (B) of treatment of negative
controls with distilled water, and DNCB-induced porcine contact
dermatitis rashes with distilled water (positive controls), or
nanocrystalline silver-derived solutions generated at starting pHs of
4, 5.6, 7, or 9. Statistical analyses, which were performed using one-
way ANOVAs with Tukey-Kramer Multiple Comparisons post tests,
are shown in Table 4. Error bars represent standard deviations.
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Page 16 of 20solution, most of the silver being delivered was inactive.
At pH 4, high quantities of Ag
+ may be dissolved into
solution initially, which then react with the carbonic
acid present to form silver carbonates. This appears to
be confirmed by the occasional presence of visible white
flakes in solution. Thus, the Ag
+ and any higher oxida-
tion state silver released may be inactivated, creating a
gradient for the release of additional silver species,
including the anti-inflammatory silver species, which are
then able to produce the anti-inflammatory/pro-healing
effects observed, including the selective apoptosis of
inflammatory cells. Previous studies have demonstrated
apoptosis induction selective to inflammatory cells of
the dermis[2,3,6]. Also, a recent study suggested that
this action was via silver interactions with cells close to
tissue surfaces which then release signals resulting in an
anti-inflammatory series of events including apoptosis
induction in inflammatory cells[7]. Treatment with pH 4
solutions resulted in somewhat decreased TNF-a
expression relative to positive controls at 72 hours, but
this was not as considerable as other treatment groups.
However, IL-8 expression was lower than that of posi-
tive controls at 72 hours, showing that treatment with
p H4s o l u t i o n sm a yb ec a p a b l eof reducing pro-inflam-
matory cytokine expression. pH 4 treatments did not
increase IL-4 expression as strongly as other treatment
groups, which may in part explain the weaker anti-
inflammatory effect observed. This also suggests that
other signalling molecules, not yet identified, were
responsible for the significant apoptosis induction
observed in the deep dermis. However, pH 4 treatments
d i dr e s u l ti nm i l d l yi n c r e a s e dE G Fe x p r e s s i o nb y7 2
hours, a mild increase in KGF expression at 24 hours,
and increased KGF-2 expression at 24 hours in areas
where re-epithelialisation would later occur beneath the
scab, followed by a mild increase in KGF-2 expression
at 72 hours in the newly forming epidermis. The
enhanced expression of these growth factors explains, at
least in part, the pro-healing activity observed, such as
enhanced rate of re-epithelialisation and protection of
keratinocytes from apoptosis induction.
Animals treated with solutions generated at a starting
pH of 5.6 showed similar mild visual improvements to
pH 4 treatments. They had no significant decreases in
erythema or oedema. Histologically, they were the slow-
est to begin re-epithelialisation and to show signs of
decreased leukocyte infiltration, both of which occurred
between 48 and 72 hours of treatment. However, this
was still enhanced relative to positive controls. pMMP-2
expression was significantly decreased relative to positive
controls at 24 hours, and similar trends (not significant)
were observed with pMMP-9, aMMP-9, and aMMP-2.
Interestingly, apoptosis induction was not observed at
24 hours of treatment, meaning that the reduction of
aMMP-2 levels could not have occurred solely through
apoptosis of inflammatory cells, and therefore may have
occurred via modulation of cellular output and activa-
tion of these molecules. Apoptosis induction was exam-
ined at 24 hours, since previous studies have shown
apoptosis induction at this time point [6,7] using nano-
crystalline silver dressings. However, it seems likely that
with pH 5.6 treatments, apoptosis induction in inflam-
matory cells occurred later, and could perhaps have
been detected at 48 hours, since reduced inflammatory
cell presence and re-epithelialisation were not observed
until 72 hours. In addition, a study of contaminated por-
cine wounds demonstrated increased apoptosis in
inflammatory cells at 48 hours with nanocrystalline sil-
ver dressings[3]. The pH 5.6 solution-treated animals
showed poor modulation of pro-inflammatory cytokine
expression relative to the other treatment groups, with
TNF-a expression increased at 72 hours, and IL-8
expression increased at 24 hours. However, the expres-
sion of TNF-a and IL-8 in this group was still lower
than that of positive controls, with IL-8 expression at 72
hours being significantly lower than positive controls.
The expression of anti-inflammatory cytokine IL-4 was
increased at 72 hours, which again suggests that apopto-
sis induction may have occurred between 24 and 72
hours in inflammatory cells. With pH 5.6 treatments,
modulation of growth factors related to re-epithelialisa-
tion was observed: EGF expression was increased at 72
hours; KGF expression was increased at 24 hours, but
decreased somewhat at 72 hours; and KGF-2 was
expressed at 24 hours in areas where re-epithelialisation
would later occur, and was expressed at 72 hours in
newly formed epidermis. Since growth factor expression
was not delayed, the delayed re-epithelialisation appears
to have been related to the late induction of apoptosis
in inflammatory cells of these tissues. The delayed heal-
ing in this group relative to other treatment groups may
be due to Ag
+ levels in solution. In distilled water, Ag
+
would be less able to react to form inactive/insoluble
species than in treatments containing carbonates or
hydroxyls, and that, in combination with the low total
silver dissolved at pH 5.6, might result in a poor gradi-
ent for drawing active silver species, including anti-
inflammatory species, into solution, while the Ag
+ pre-
sent could counteract the pro-healing/anti-inflammatory
activity to some degree, delaying healing. The early
upregulation of KGF may have protected keratinocytes
from Ag
+-induced apoptosis. Interestingly, solutions
generated in distilled water have the highest antimicro-
bial activity, corroborating the idea that most of the sil-
ver present in solution is positively charged
(unpublished data).
Solutions generated at a starting pH of 7 showed
visual improvements during the treatment period, with
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pathology showed that re-epithelialisation had begun by
48 hours, with greatly decreased inflammatory cell infil-
tration occurring by 72 hours. However, the epidermis
was very thick with deep ridges. While some researchers
have suggested that this tissue morphology is beneficial
[41], as it indicates that the newly forming tissues are
well anchored and less likely to dehisce, others have
suggested that this tissue morphology is caused by
chronic mechanical shear[42], which, in this case, would
be due to animals attempting to scratch their backs or
remove their dressings, possibly due to discomfort
caused by the treatment. The latter seems unlikely,
since animals treated with pH 9 solutions did not
demonstrate epidermal thickening or extended rete
ridges, although they were exposed to the same quantity
of silver and even more calcium hydroxide. If the treat-
m e n tw a si r r i t a t i n g ,t h es a m ee f f e c ts h o u l dh a v eb e e n
observed in the pH 9 treatment group. A third possibi-
lity is that the epidermal tissue only appeared to be
thicker in this group due to angled slices through the
tissue during slide preparation. While a fourth possibi-
lity is that hyperkeratinisation was occurring, this seems
unlikely, considering the low expression of KGF and
KGF-2 at 24 hours relative to other treatment groups.
There was a trend towards decreased MMP expression
and activation with pH 7 treatments, but this was not
significant. At 72 hours, only one of three animals
showed strong MMP expression, while positive controls
h a dt w oo u to ft h r e ea n i m a l ss h o w i n gs t r o n gM M P
expression. Although strong apoptosis induction was
observed in the dermis with pH 7 treatments, some
apoptosis induction was also observed in the epidermis,
suggesting either a less selective or less protective effect
with this treatment. One possible explanation for this is
that there may not have been enough hydroxyls present
in the solution to bind to all the Ag
+ released, and thus
the Ag
+ caused apoptosis in the epidermis. However, if
this was the case, a similar observation would have been
expected with the pH 5.6 treatment, where high levels
of Ag
+ seem more likely. Furthermore, calculations
based on the amount of silver and amount of calcium
hydroxide present in the solutions suggest that there
should have been sufficient hydroxyl ions to react with
the Ag
+. It also should be noted that the apoptosis
i n d u c t i o ni nt h ee p i d e r m i sw a sn o ta ss t r o n ga st h a t
observed previously with silver nitrate treatments (which
contain Ag
+ only)[6], and that the increased expression
observed did not reach statistical significance. Expres-
sion of pro-inflammatory molecules was modulated via
pH 7 treatments, with TNF-a downregulated by 72
hours, and IL-8 expression low at both 24 and 72 hours.
In addition, the expression of anti-inflammatory cyto-
kine IL-4 was increased at 72 hours, along with EGF.
Thus pH 7 solutions provide active silver species which
generate anti-inflammatory/pro-healing activity. How-
ever, expression of KGF and KGF-2 was low at 24 hours
compared to other treatment groups. Since these mole-
cules are involved with protection of keratinocytes from
apoptosis, this may partially explain why some apoptosis
occurred in the epidermis with this treatment.
Solutions generated at a starting pH of 9 showed the
most visual improvement, with significant reductions in
both erythema and oedema scores within two days of
treatment. Histologically, re-epithelialisation occurred
the earliest, and the most normal tissue morphology was
observed at 72 hours. Apoptosis induction was observed
in the deep dermis at 24 hours, but not in the newly
forming epidermis. The induction levels were not as
high as those seen with pH 4 or pH 7 treatments, but
since re-epithelialisation was already occurring in some
of the pH 9 treated animals, it is possible that the peak
of apoptosis induction had already passed at 24 hours.
TNF-a expression was low throughout the treatment
period, but, interestingly, IL-8 expression increased over
time, although not to the levels observed with the posi-
tive controls. Expression of IL-4 was increased through-
out the treatment period, at least partially explaining the
anti-inflammatory activity observed. In addition, EGF
expression was increased throughout the treatment per-
iod, while KGF expression was increased at 24 h, and
KGF-2 expression was increased throughout the experi-
ment, particularly in newly forming epidermis and fibro-
blasts. This early increased expression of growth factors
involved in re-epithelialisation and formation of granula-
tion tissue explains, at least in part, the enhanced pro-
healing activity observed with the pH 9 treatments.
Overall, these results suggest that at higher pHs more of
the total silver in solution is active anti-inflammatory
species, perhaps Ag
(0) clusters[9]. The Ag
+ released into
solution along with these species may react with hydro-
xyl ions from the calcium hydroxide in solution[43]
causing their re-precipitation, preventing them from
inhibiting healing, and resulting in a gradient towards
the release of more anti-inflammatory silver. The levels
of Ag
+ in nanocrystalline silver containing solutions
generated at different pHs will be tested in the future.
It should be noted that serum and wound fluids con-
tain 160-185 mg/L[44] calcium. The daily calcium pro-
vided in the pH 7 and 9 treatments was thus <0.0025%
and <0.012% of the calcium load per litre of blood,
respectively. Therefore, it is unlikely that the calcium
provided was a significant contributor to the effects
observed.
Conclusions
Overall, nanocrystalline silver-derived solutions appear
to have anti-inflammatory/pro-healing activity,
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this activity does not correlate with total silver, solutions
generated under different conditions may have varying
concentrations of different silver species, only some of
which have anti-inflammatory activity. Future studies
will focus on improving understanding of which species
have anti-inflammatory activity and what conditions are
necessary to generate or dissolve these species. Nano-
crystalline silver-derived solutions show promise for a
variety of anti-inflammatory treatment applications.
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